For the most up to date information on COVID-19 please visit the Department of Health Website.
Learn more about how the AIHW is assisting the COVID-19 response and our broader work on communicable diseases.
The main purpose of the NOPSAD collection is to aggregate standardised jurisdictional data on the number of clients accessing pharmacotherapy for the treatment of opioid dependence, the number of prescribers participating in the delivery of pharmacotherapy treatment, and quantitative information about the prescribing sector. As such, national information on pharmacotherapy can be reported.
from 30 June 2004 to 30 June 2018
National and state
Covers the provision of opioid pharmacotherapy treatment, the practitioners who prescribe the treatment, the dosing sites who dispense the pharmacotherapy drugs, and the clients receiving the opioid pharmacotherapy treatment. The following pharmacotherapies are currently recommended for the treatment of opioid dependency:
Metadata information and data quality statement (DQS)
NOPSAD 2018 DQS
External links and information
Alcohol and other drug treatment services in Australia 2017–18
We'd love to know any feedback that you have about the AIHW website, its contents or reports.
The browser you are using to browse this website is outdated and some features may not display properly or be accessible to you. Please use a more recent browser for the best user experience.